Table 1 Population characteristics
Variable | N | % |
|---|---|---|
Age | 65 ± 6 |  |
Sex (M/F) | 15/7 | 68/32 |
Etiology of liver disease | ||
 Chronic HCV | 14 | 64 |
 Chronic HBV | 3 | 14 |
 NASH | 3 | 14 |
 Alcohol abuse | 1 | 4 |
 Cryptogenic | 1 | 4 |
Alpha-fetoprotein | ||
 Pre-treatment [median (range), ng/ml] | 22.95 (0.9–11.309) |  |
 Post-treatment [median (range), ng/ml] | 10 (2.4–31.813) |  |
Child-Pugh Score A/B/C | 19/3/0 | 86/14/0 |
Radiation dose [mean ± SD, GBq] | 2.1 ± 1.5 |  |
Time between pre-treatment MRI and RE [mean ± SD, days] | 60 ± 22 |  |
Time between radioembolization and 6w follow-up imaging [mean ± SD, days] | 57 ± 21 |  |
Time between RE and follow-up MRI [mean ± SD, days] | 137 ± 41 |  |